Metropolitan Life Insurance Company (MetLife)’s CEL-SCI Corp CVM Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CVM Stock Details CVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-164	Closed	-$35K	–	2350
2021 Q4	$35K	Sell	164 -54	-25%	-$16.5K	﹤0.01%	2727
2021 Q3	$72K	Sell	218 -142	-39%	-$41.4K	﹤0.01%	2692
2021 Q2	$93.7K	Buy	360 +44	+14%	+$27.2K	﹤0.01%	2609
2021 Q1	$144K	Sell	316 -35	-10%	-$19.1K	﹤0.01%	2234
2020 Q4	$123K	Hold	351	–	–	﹤0.01%	2247
2020 Q3	$134K	Hold	351	–	–	﹤0.01%	2045
2020 Q2	$157K	Hold	351	–	–	﹤0.01%	1971
2020 Q1	$122K	Buy	351 +51	+17%	+$18.6K	﹤0.01%	1908
2019 Q4	$82.2K	Sell	300 -53	-15%	-$12.5K	﹤0.01%	2429
2019 Q3	$94.7K	Buy	+353	New	+$82.7K	﹤0.01%	2330

Other funds holding CVM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CVM Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of CEL-SCI Corp (CVM) in Q1 2022, closing a stake of 164 shares — an estimated $35K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CVM in Q3 2019 and held it in 10 quarters. The position peaked at $157K in Q2 2020. 110 funds tracked by Wall St. Rank hold CVM as of Q1 2022.

Metropolitan Life Insurance Company (MetLife) reported no remaining CEL-SCI Corp position as of Q1 2022 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 164 CEL-SCI Corp shares in Q1 2022, an estimated $35K.
Metropolitan Life Insurance Company (MetLife) first reported a position in CEL-SCI Corp in Q3 2019 and held it in 10 quarters.
Metropolitan Life Insurance Company (MetLife)'s CEL-SCI Corp position peaked at $157K in Q2 2020.
110 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.